| Targeted brain tumor radiotherapy using an Auger emitter G Pirovano, SA Jannetti, LM Carter, A Sadique, S Kossatz, N Guru, ... Clinical Cancer Research 26 (12), 2871-2881, 2020 | 87 | 2020 |
| Poly (ADP-ribose) polymerase (PARP) inhibitors and radiation therapy SA Jannetti, BM Zeglis, MR Zalutsky, T Reiner Frontiers in Pharmacology 11, 170, 2020 | 74 | 2020 |
| PARP-1–targeted radiotherapy in mouse models of glioblastoma SA Jannetti, G Carlucci, B Carney, S Kossatz, L Shenker, LM Carter, ... Journal of Nuclear Medicine 59 (8), 1225-1233, 2018 | 62 | 2018 |
| From mollusks to medicine: a venomics approach for the discovery and characterization of therapeutics from Terebridae peptide toxins A Verdes, P Anand, J Gorson, S Jannetti, P Kelly, A Leffler, D Simpson, ... Toxins 8 (4), 117, 2016 | 50 | 2016 |
| The role of proton transfer in surface-induced dissociation Z Gregg, W Ijaz, S Jannetti, GL Barnes The Journal of Physical Chemistry C 118 (38), 22149-22155, 2014 | 25 | 2014 |
| Evaluation of an 131I-labeled HER2-specific single domain antibody fragment for the radiopharmaceutical therapy of HER2-expressing cancers Y Feng, R Meshaw, D McDougald, Z Zhou, XG Zhao, SA Jannetti, ... Scientific reports 12 (1), 3020, 2022 | 21 | 2022 |
| Discriminating radiation injury from recurrent tumor with [18F]PARPi and amino acid PET in mouse models PL Donabedian, S Kossatz, JA Engelbach, SA Jannetti, B Carney, ... EJNMMI research 8, 1-10, 2018 | 19 | 2018 |
| Improved radiosynthesis of 123I-MAPi, an auger theranostic agent TC Wilson, SA Jannetti, N Guru, N Pillarsetty, T Reiner, G Pirovano International journal of radiation biology 99 (1), 70-76, 2023 | 18 | 2023 |
| Effective treatment of human breast carcinoma xenografts with single-dose 211At-labeled anti-HER2 single-domain antibody fragment Y Feng, R Meshaw, XG Zhao, S Jannetti, G Vaidyanathan, MR Zalutsky Journal of Nuclear Medicine 64 (1), 124-130, 2023 | 17 | 2023 |
| Therapeutic efficacy of single-dose iso-[211At] SAGMB-anti-HER2 sdAb in mice with subcutaneous HER2-expressing breast carcinoma xenografts Y Feng, S Jannetti, R Meshaw, G Vaidyanathan, M Zalutsky Journal of Nuclear Medicine 62 (supplement 1), 1484-1484, 2021 | 2 | 2021 |
| Low-level whole-brain radiation enhances theranostic potential of single-domain antibody fragments for human epidermal growth factor receptor type 2 (HER2)-positive brain … D Procissi, SA Jannetti, M Zannikou, Z Zhou, D McDougald, D Kanojia, ... Neuro-oncology advances 4 (1), vdac135, 2022 | 1 | 2022 |
| Low Level Whole-Brain Radiation Enhances Theranostic Potential Of Single Domain Antibody Fragments For HER2-Positive Brain Metastases D Procissi, SA Jannetti, M Zannikou, Z Zhou, D McDougald, D Kanojia, ... bioRxiv, 2022.04. 19.488555, 2022 | | 2022 |
| Neuro-Oncology Advances D Procissi, SA Jannetti, M Zannikou, Z Zhou, D McDougald, D Kanojia, ... | | 2022 |
| PARP1-Targeted Radiotherapies S Jannetti The Graduate Center of the City University of New York, 2020 | | 2020 |
| PARP-1 Targeted Radiotherapy in Mouse Models of Glioblastoma B Salinas Rodríguez, S Jannetti Society of Nuclear Medicine & Molecular Imaging, 2018 | | 2018 |
| Low-temperature copper-catalyzed formal Bergman cycloaromatizations of bis (2-arylethynyl) benzenes TS Hughes, ES Thamban, SA Jannetti, JA Olson, MR Scudder ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 242, 2011 | | 2011 |
